134 related articles for article (PubMed ID: 22143660)
21. Factors contributing to the decision for euthanasia of dogs with congestive heart failure.
Mallery KF; Freeman LM; Harpster NK; Rush JE
J Am Vet Med Assoc; 1999 Apr; 214(8):1201-4. PubMed ID: 10212683
[TBL] [Abstract][Full Text] [Related]
22. Principles of treatment for canine lymphoma.
Ettinger SN
Clin Tech Small Anim Pract; 2003 May; 18(2):92-7. PubMed ID: 12831068
[TBL] [Abstract][Full Text] [Related]
23. Follow-up study of owner attitudes toward home care of paraplegic dogs.
Bauer M; Glickman N; Glickman L; Toombs J; Golden S; Skowronek C
J Am Vet Med Assoc; 1992 Jun; 200(12):1809-16. PubMed ID: 1639682
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
[TBL] [Abstract][Full Text] [Related]
25. Owner perceptions of their cat's quality of life when treated with a modified University of Wisconsin-Madison protocol for lymphoma.
Thornton LA; Cave N; Bridges JP; Stell AJ
J Feline Med Surg; 2018 Apr; 20(4):356-361. PubMed ID: 28569081
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Fahey CE; Milner RJ; Barabas K; Lurie D; Kow K; Parfitt S; Lyles S; Clemente M
J Am Vet Med Assoc; 2011 Jul; 239(2):209-15. PubMed ID: 21756176
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of serial determinations of lactate dehydrogenase activity used to predict recurrence in dogs with lymphoma.
Marconato L; Crispino G; Finotello R; Mazzotti S; Zini E
J Am Vet Med Assoc; 2010 May; 236(9):969-74. PubMed ID: 20433396
[TBL] [Abstract][Full Text] [Related]
29. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
Northrup NC; Gieger TL; Kosarek CE; Saba CF; LeRoy BE; Wall TM; Hume KR; Childress MO; Keys DA
Vet Comp Oncol; 2009 Mar; 7(1):38-44. PubMed ID: 19222829
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival after combination chemotherapy for bilateral renal malignant lymphoma in a dog.
Batchelor DJ; Bright SR; Ibarrola P; Tzannes S; Blackwood L
N Z Vet J; 2006 Jun; 54(3):147-50. PubMed ID: 16751846
[TBL] [Abstract][Full Text] [Related]
32. The staging and treatment of multicentric high-grade lymphoma in dogs: a review of recent developments and future prospects.
Marconato L
Vet J; 2011 Apr; 188(1):34-8. PubMed ID: 20627636
[TBL] [Abstract][Full Text] [Related]
33. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma.
Khanna C; Lund EM; Redic KA; Hayden DW; Bell FW; Goulland EL; Klausner JS
J Am Vet Med Assoc; 1998 Oct; 213(7):985-90. PubMed ID: 9776993
[TBL] [Abstract][Full Text] [Related]
34. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
Gray KN; Raulston GL; Gleiser CA; Jardine JH
J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115
[TBL] [Abstract][Full Text] [Related]
35. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
[TBL] [Abstract][Full Text] [Related]
36. Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation.
Deeg HJ; Appelbaum FR; Weiden PL; Hackman RC; Graham TC; Storb RC
Am J Vet Res; 1985 Sep; 46(9):2016-8. PubMed ID: 3901841
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
Chang Y; Mellor DJ; Anderson TJ
J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
[TBL] [Abstract][Full Text] [Related]
38. A toxicity study of low-dose rate half-body irradiation and chemotherapy in dogs with lymphoma.
Lurie DM; Kent MS; Fry MM; Théon AP
Vet Comp Oncol; 2008 Dec; 6(4):257-67. PubMed ID: 19178684
[TBL] [Abstract][Full Text] [Related]
39. Owner assessment of dogs' quality of life following treatment of neoplastic haemoperitoneum.
Crawford AH; Tivers MS; Adamantos SE
Vet Rec; 2012 Jun; 170(22):566. PubMed ID: 22550120
[No Abstract] [Full Text] [Related]
40. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
